These differentially expressed genes were enriched in various cancer-related pathways, including cytokine−cytokine receptor interaction, PPAR, Wnt, IL−17, the MAPK signaling pathway, and transcriptional misregulation in cancer (Figure 6B). The gene discussed is IL17A; the disease is cancer.